
Healthcare and pharma marketing professional Renée Mellas has returned to Area 23, an FCB Health company, as executive vice president …
An American doctor working with Ebola patients in Liberia has been infected with the virus as health officials struggle to …

Google is to collect samples of human tissue from thousands of people as part of an experiment that could help …

A leading European doctors’ group is warning that new data protection rules could make cancer research ‘impossible’ whilst also adding …

Gilead and Janssen are set to face off in Europe after the CHMP recommended both of their rival blood cancer …

Whilst seemingly more and more barriers are being erected to slow down the adoption of new medicines, there is a …

GSK has submitted a regulatory application to the European Medicines Agency for its malaria vaccine candidate RTS,S and hopes it …
Pharma and governments need to put their heads together urgently in order to tackle the threat of antimicrobial resistance (AMR), …

Diagnostic information services firm Quest Diagnostics has confirmed that Vicky Gregg is to serve as a director on its board. Gregg …

In updated guidance NICE has extended its recommendation of Efient (prasugrel) in combination with aspirin for preventing blood clots in …

The Food and Drug Administration has approved Gilead Sciences new treatment Zydelig (idelalisib) to treat three types of blood cancer. …

Dr Dinesh Bhugra who has served as chair of the Mental Health Foundation for three years has been appointed as …

An investigation by The BMJ has raised fresh concerns about Boehringer’s top-selling blood thinner Pradaxa (dabigatran) and the regulatory decisions …

GlaxoSmithKline posted a 4% slide in revenue for the second quarter today as its recovery from a slew of patent …

The Royal College of Nursing says that whilst a new wireless diagnostic patch is certainly innovative, they are concerned that …

Two big-name oncology brands, Bristol-Myers Squibb’s Yervoy and Astellas Pharma’s Xtandi, have been given the nod by drug costs watchdog …

Clinical diagnostics firm Agena Bioscience has confirmed that Peter Dansky has joined the company as its chief executive and will …

Allergan is to cut 1,500 jobs as part of a restructure which it believes will make pre-tax savings of around …

AZ’s MedImmune has entered into a clinical trial collaboration with US biotech firm Advaxis to help develop new cancer immunotherapies. …

UK researchers are to gain access to compounds from seven pharma companies in a partnership with the Medical Research Council …